INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 112 filers reported holding INSYS THERAPEUTICS INC NEW in Q4 2017. The put-call ratio across all filers is 1.10 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $2,195,000 | -65.3% | 627,077 | 0.0% | 0.00% | -50.0% |
| Q3 2018 | $6,321,000 | +114.3% | 627,077 | +54.0% | 0.00% | +100.0% |
| Q2 2018 | $2,949,000 | -45.7% | 407,297 | -54.7% | 0.00% | -50.0% |
| Q1 2018 | $5,429,000 | -42.7% | 898,911 | -8.8% | 0.00% | -33.3% |
| Q4 2017 | $9,482,000 | +8.3% | 985,712 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $8,753,000 | -29.8% | 985,712 | 0.0% | 0.00% | -40.0% |
| Q2 2017 | $12,469,000 | +20.4% | 985,712 | 0.0% | 0.01% | +25.0% |
| Q1 2017 | $10,360,000 | +204.0% | 985,712 | +166.1% | 0.00% | +300.0% |
| Q4 2016 | $3,408,000 | -3.5% | 370,399 | +18.1% | 0.00% | -50.0% |
| Q3 2016 | $3,533,000 | +3.2% | 313,734 | +18.6% | 0.00% | 0.0% |
| Q2 2016 | $3,423,000 | -19.1% | 264,534 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $4,230,000 | -31.1% | 264,534 | +23.3% | 0.00% | -33.3% |
| Q4 2015 | $6,142,000 | +74.0% | 214,534 | +73.0% | 0.00% | +50.0% |
| Q3 2015 | $3,529,000 | – | 123,998 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 5,406,844 | $52,014,000 | 0.66% |
| ETF MANAGERS GROUP, LLC | 282,268 | $3,255,000 | 0.24% |
| Mirae Asset Global Investments Co., Ltd. | 1,470,996 | $14,151,000 | 0.19% |
| Financial Gravity Companies, Inc. | 4,467 | $42,000 | 0.05% |
| GSA CAPITAL PARTNERS LLP | 67,200 | $646,000 | 0.04% |
| TCI Wealth Advisors, Inc. | 7,766 | $75,000 | 0.03% |
| Freedom Investment Management, Inc. | 64,741 | $623,000 | 0.03% |
| GAM Holding AG | 83,940 | $808,000 | 0.02% |
| SFMG, LLC | 11,994 | $115,000 | 0.02% |
| SHELL ASSET MANAGEMENT CO | 95,127 | $915,000 | 0.02% |